Metastatic breast cancer (MBC) remains one of the most challenging malignancies to treat, requiring a multimodal approach for effective management. Chemotherapy plays a vital role in treatment, especially for patients with hormone receptor-negative or HER2-positive disease who do not respond to targeted therapies. Among the chemotherapeutic agents, capecitabine has emerged as a cornerstone in...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek